Exclusive

Publication

Byline

US Patent Issued to AB Enzymes Finland on April 14 for "Xylanase variants" (Finnish, German Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,960, issued on April 14, was assigned to AB Enzymes Finland Oy (Rajamaki, Finland). "Xylanase variants" was invented by Marja Paloheimo (R... Read More


US Patent Issued to 10X GENOMICS on April 14 for "Methods and systems for droplet-based single cell barcoding" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,961, issued on April 14, was assigned to 10X GENOMICS INC. (Pleasanton, Calif.). "Methods and systems for droplet-based single cell barcod... Read More


US Patent Issued to Singular Genomics Systems on April 14 for "High density sequencing and multiplexed priming" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,962, issued on April 14, was assigned to Singular Genomics Systems Inc. (San Diego). "High density sequencing and multiplexed priming" was... Read More


US Patent Issued to Tecan Genomics on April 14 for "Depletion of abundant uninformative sequences" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,963, issued on April 14, was assigned to Tecan Genomics Inc. (Redwood City, Calif.). "Depletion of abundant uninformative sequences" was i... Read More


US Patent Issued to Medizinische Hochschule Hannover on April 14 for "Compound for treatment of heart failure" (German, Dutch Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,964, issued on April 14, was assigned to Medizinische Hochschule Hannover (Hannover, Germany). "Compound for treatment of heart failure" w... Read More


US Patent Issued to Alnylam Pharmaceuticals on April 14 for "Modified double stranded oligonucleotide" (Massachusetts Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,965, issued on April 14, was assigned to Alnylam Pharmaceuticals Inc. (Cambridge, Mass.). "Modified double stranded oligonucleotide" was i... Read More


US Patent Issued to SIRNAOMICS on April 14 for "SiRNA compound that inhibits complement factor B (CFB)" (Maryland Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,967, issued on April 14, was assigned to SIRNAOMICS INC. (Gaithersburg, Md.). "SiRNA compound that inhibits complement factor B (CFB)" was... Read More


US Patent Issued to The Regents of the University of Colorado, a body corporate on April 14 for "Methods and compositions for reprogramming cells" (Colorado Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,968, issued on April 14, was assigned to The Regents of the University of Colorado, a body corporate (Denver). "Methods and compositions f... Read More


US Patent Issued to Askbio on April 14 for "Expression control using a regulatable intron" (British Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,969, issued on April 14, was assigned to Askbio Inc. (Research Triangle Park, N.C.). "Expression control using a regulatable intron" was i... Read More


US Patent Issued to Ionis Pharmaceuticals on April 14 for "Compositions for modulating C9ORF72 expression" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,970, issued on April 14, was assigned to Ionis Pharmaceuticals Inc. (Carlsbad, Calif.). "Compositions for modulating C9ORF72 expression" w... Read More